[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100338251":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":25,"centralContacts":29,"locations":36,"responsibleParty":141,"collaborators":11,"id":143,"slug":144,"hasResults":145,"nctId":146,"briefTitle":147,"officialTitle":148,"acronym":11,"eligibilityCriteria":149,"healthyVolunteers":145,"sex":150,"minAge":151,"maxAge":152,"enrollmentInfo":153,"targetDuration":11,"studyType":156,"phases":157,"briefSummary":159,"conditions":160,"keywords":11,"overallStatus":84,"whyStopped":11,"lastUpdateSubmitDate":162,"lastUpdatePostDateStruct":163,"startDateStruct":166,"completionDateStruct":168,"leadSponsor":170,"locationsCount":171},{"fullName":5,"class":6},"CSL Behring","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"IgPro10 (dose level 1)","EXPERIMENTAL",null,[13],"Biological: IgPro10",{"label":15,"type":10,"description":11,"interventionNames":16},"IgPro10 (dose level 2)",[13],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"BIOLOGICAL","IgPro10","Normal human immunoglobulin G administered intravenously",[9,15],[24],"Privigen",[26],{"name":27,"affiliation":5,"role":28},"Study Director","STUDY_DIRECTOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":34,"email":35},"Trial Registration Coordinator","CONTACT","6108784697","+1","clinicaltrials@cslbehring.com",[37,51,62,72,82,96,106,118,128],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":11},"Phoenix Children's Hospital","COMPLETED","Phoenix","Arizona","85016","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-112.07404,33.44838,{"lat":49,"lon":48},{"facility":52,"status":53,"city":54,"state":55,"zip":56,"country":43,"countryCode":44,"cosmosGeoPoint":57,"geoPoint":61,"contacts":11},"Children's Hospital of Los Angeles","WITHDRAWN","Los Angeles","California","90027",{"type":46,"coordinates":58},[59,60],-118.24368,34.05223,{"lat":60,"lon":59},{"facility":63,"status":53,"city":64,"state":65,"zip":66,"country":43,"countryCode":44,"cosmosGeoPoint":67,"geoPoint":71,"contacts":11},"University of Iowa Hospitals and Clinics","Iowa City","Iowa","52242-1009",{"type":46,"coordinates":68},[69,70],-91.53017,41.66113,{"lat":70,"lon":69},{"facility":73,"status":53,"city":74,"state":75,"zip":76,"country":43,"countryCode":44,"cosmosGeoPoint":77,"geoPoint":81,"contacts":11},"Akron Children's Hospital","Akron","Ohio","44647",{"type":46,"coordinates":78},[79,80],-81.51901,41.08144,{"lat":80,"lon":79},{"facility":83,"status":84,"city":85,"state":86,"zip":87,"country":43,"countryCode":44,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Children's Hospital of Philadelphia","RECRUITING","Philadelphia","Pennsylvania","19104",{"type":46,"coordinates":89},[90,91],-75.16362,39.95238,{"lat":91,"lon":90},[94],{"name":95,"role":32,"phone":11,"phoneExt":11,"email":11},"Use Central Contact",{"facility":97,"status":53,"city":98,"state":99,"zip":100,"country":43,"countryCode":44,"cosmosGeoPoint":101,"geoPoint":105,"contacts":11},"Le Bonheur Children's Hospital","Memphis","Tennessee","38105",{"type":46,"coordinates":102},[103,104],-90.04898,35.14953,{"lat":104,"lon":103},{"facility":107,"status":84,"city":108,"state":109,"zip":110,"country":43,"countryCode":44,"cosmosGeoPoint":111,"geoPoint":115,"contacts":116},"Neurology Rare Disease Center","Flower Mound","Texas","75028",{"type":46,"coordinates":112},[113,114],-97.09696,33.01457,{"lat":114,"lon":113},[117],{"name":95,"role":32,"phone":11,"phoneExt":11,"email":11},{"facility":119,"status":39,"city":120,"state":121,"zip":122,"country":43,"countryCode":44,"cosmosGeoPoint":123,"geoPoint":127,"contacts":11},"Children's Specialty Group","Norfolk","Virginia","23507",{"type":46,"coordinates":124},[125,126],-76.28522,36.84681,{"lat":126,"lon":125},{"facility":129,"status":84,"city":130,"state":131,"zip":132,"country":43,"countryCode":44,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"Seattle Children's Hospital","Seattle","Washington","98105",{"type":46,"coordinates":134},[135,136],-122.33207,47.60621,{"lat":136,"lon":135},[139],{"name":140,"role":32,"phone":11,"phoneExt":11,"email":11},"Central Contact",{"type":142,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100338251","phase-4-two-dose-levels-of-privigen-in-pediatric-cidp-100338251",false,"NCT03684018","Two Dose Levels of Privigen in Pediatric CIDP","Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP","Inclusion Criteria:\n\n* \\- Male or female subjects 2 to ≤ 17 years of age with confirmed or possible CIDP.\n\nExclusion Criteria:\n\n* \\- Absence of CIDP symptoms\n* -History or family history of inherited neuropathy\n* -Diagnosed developmental delay or regression\n* -History of thrombotic episode\n* -Known or suspected hypersensitivity to Privigen\n* -Known allergic or other severe reactions to blood products\n* -Female subject of childbearing potential either not using or not willing to use a medically reliable method of contraception or not sexually abstinent during the study\n* -Pregnant or breastfeeding mother\"","ALL","2 Years","17 Years",{"count":154,"type":155},30,"ESTIMATED","INTERVENTIONAL",[158],"PHASE4","A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment",[161],"Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","2026-05-28",{"date":164,"type":165},"2026-06-01","ACTUAL",{"date":167,"type":165},"2019-02-28",{"date":169,"type":155},"2029-12-20",{"name":5,"class":6},9]